Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-16

FDA Approved: PRASUGREL — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s generic prasugrel (Original Application) for use as an antiplatelet therapy to reduce cardiovascular events in patients with acute c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

ORIG AP for PRASUGREL (PRASUGREL)